Antifascism, the 1956 Revolution and the politics of communist autobiographies in Hungary 1944-2000

This is a postprint of an article whose final and definitive form has been published in Europe-Asia Studies © 2006 University of Glasgow; Europe-Asia Studies is available online at http://www.informaworld.com.Using oral history, this contribution explores the reshaping of individuals' public and private autobiographies in response to different political environments. In particular, it analyses the testimony of those who were communists in Hungary between 1945 and 1956, examining how their experiences of fascism, party membership, the 1956 Revolution and the collapse of communism led them in each case to refashion their life stories. Moreover, it considers how their biographies played varying functions at different points in their lives: to express identification with communism, to articulate resistance and to communicate ambition before 1956; to protect themselves from the state after 1956; and to rehabilitate themselves morally in a society which stigmatised them after 1989.I didn't use this word 'liberation' (felszabadulás), because in 1956 my life really changed. Everybody's lives went through a great change, but mine especially. … I wasn't disgusted with myself that I had called the arrival of the Red Army in 1945 a liberation, but [after 1956] I didn't use it anymore

General anaesthetic and airway management practice for obstetric surgery in England: a prospective, multi-centre observational study

There are no current descriptions of general anaesthesia characteristics for obstetric surgery, despite recent changes to patient baseline characteristics and airway management guidelines. This analysis of data from the direct reporting of awareness in maternity patients' (DREAMY) study of accidental awareness during obstetric anaesthesia aimed to describe practice for obstetric general anaesthesia in England and compare with earlier surveys and best-practice recommendations. Consenting patients who received general anaesthesia for obstetric surgery in 72 hospitals from May 2017 to August 2018 were included. Baseline characteristics, airway management, anaesthetic techniques and major complications were collected. Descriptive analysis, binary logistic regression modelling and comparisons with earlier data were conducted. Data were collected from 3117 procedures, including 2554 (81.9%) caesarean deliveries. Thiopental was the induction drug in 1649 (52.9%) patients, compared with propofol in 1419 (45.5%). Suxamethonium was the neuromuscular blocking drug for tracheal intubation in 2631 (86.1%), compared with rocuronium in 367 (11.8%). Difficult tracheal intubation was reported in 1 in 19 (95%CI 1 in 16-22) and failed intubation in 1 in 312 (95%CI 1 in 169-667). Obese patients were over-represented compared with national baselines and associated with difficult, but not failed intubation. There was more evidence of change in practice for induction drugs (increased use of propofol) than neuromuscular blocking drugs (suxamethonium remains the most popular). There was evidence of improvement in practice, with increased monitoring and reversal of neuromuscular blockade (although this remains suboptimal). Despite a high risk of difficult intubation in this population, videolaryngoscopy was rarely used (1.9%)

Effects of sodium and potassium supplementation on endothelial function: a fully controlled dietary intervention study

High Na and low K intakes have adverse effects on blood pressure, which increases the risk for CVD. The role of endothelial dysfunction and inflammation in this pathophysiological process is not yet clear. In a randomised placebo-controlled cross-over study in untreated (pre)hypertensives, we examined the effects of Na and K supplementation on endothelial function and inflammation. During the study period, subjects were provided with a diet that contained 2·4 g/d of Na and 2·3 g/d of K for a 10 460 kJ (2500 kcal) intake. After 1-week run-in, subjects received capsules with supplemental Na (3·0 g/d), supplemental K (2·8 g/d) or placebo, for 4 weeks each, in random order. After each intervention, circulating biomarkers of endothelial function and inflammation were measured. Brachial artery flow-mediated dilation (FMD) and skin microvascular vasomotion were assessed in sub-groups of twenty-two to twenty-four subjects. Of thirty-seven randomised subjects, thirty-six completed the study. Following Na supplementation, serum endothelin-1 was increased by 0·24 pg/ml (95 % CI 0·03, 0·45), but no change was seen in other endothelial or inflammatory biomarkers. FMD and microvascular vasomotion were unaffected by Na supplementation. K supplementation reduced IL-8 levels by 0·28 pg/ml (95 % CI 0·03, 0·53), without affecting other circulating biomarkers. FMD was 1·16 % (95 % CI 0·37, 1·96) higher after K supplementation than after placebo. Microvascular vasomotion was unaffected. In conclusion, a 4-week increase in Na intake increased endothelin-1, but had no effect on other endothelial or inflammatory markers. Increased K intake had a beneficial effect on FMD and possibly IL-8, without affecting other circulating endothelial or inflammatory biomarkers

Pure flavonoid epicatechin and whole genome gene expression profiles in circulating immune cells in adults with elevated blood pressure: A randomised double-blind, placebo-controlled, crossover trial

<div><p>Cocoa consumption has beneficial cardiometabolic effects, but underlying mechanisms remain unclear. Epicatechin, the cocoa major monomeric flavan-3-ol, is considered to contribute to these cardio-protective effects. We investigated effects of pure epicatechin supplementation on gene expression profiles of immune cells in humans. In a double blind, placebo-controlled cross-over trial, 32 (pre)hypertensive subjects aged 30 to 80, received two 4-week interventions, i.e. epicatechin (100mg/day) or placebo with a 4-week wash-out between interventions. Gene expression profiles of peripheral blood mononuclear cells were determined before and after both interventions. Epicatechin regulated 1180 genes, of which 234 differed from placebo. Epicatechin upregulated gene sets involved in transcription and tubulin folding and downregulated gene sets involved in inflammation, PPAR signalling and adipogenesis. Several negatively enriched genes within these gene sets were involved in insulin signalling. Most inhibited upstream regulators within the epicatechin intervention were cytokines or involved in inflammation. No upstream regulators were identified compared to placebo. Epicatechin, a cocoa flavan-3-ol, reduces gene expression involved in inflammation, PPAR-signalling and adipogenesis in immune cells. Effects were mild but our findings increase our understanding and provide new leads on how epicatechin rich products like cocoa may affect immune cells and exert cardiometabolic protective effects.</p></div

Flow diagram showing the number of genes of which the expression was changed after 4-week epicatechin or placebo supplementation and the number of genes that significantly changed in expression between the epicatechin or placebo intervention.

<p>A change was considered significant if two-sided <i>P</i><0.05.</p

Gene sets significantly downregulated within the epicatechin intervention (epicatechin) and between intervention arms (epicatechin versus placebo).

<p>Gene sets significantly downregulated within the epicatechin intervention (epicatechin) and between intervention arms (epicatechin versus placebo).</p

Expression heat map of contributing genes within the downregulated gene sets involved in inflammation, PPAR signalling, AMPK signalling and adipogenesis.

<p>Subjects were hierarchically clustered via the complete agglomeration method. Expression changes are indicated as individual signal-log-ratios (SLR) of T = 4 weeks versus T = 0 weeks. Down-regulation or up-regulation of gene expression is presented on a colour scale, ranging from green (downregulated, SLR ≤-0.25) to red (upregulated, SLR ≥ 0.25).</p

Gene sets significantly upregulated within the epicatechin intervention (epicatechin) and between intervention arms (epicatechin versus placebo).

<p>Gene sets significantly upregulated within the epicatechin intervention (epicatechin) and between intervention arms (epicatechin versus placebo).</p

Baseline characteristics of 32 untreated (pre)hypertensive healthy subjects included in the microarray analysis.

<p>Baseline characteristics of 32 untreated (pre)hypertensive healthy subjects included in the microarray analysis.</p